Adial Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Adial Pharmaceuticals, Inc.‘s stocks are currently a part of 12 hedge funds’ portfolios, which represents 6.97% of the total amount of its stocks outstanding. This makes up a total of 1.74M shares of Adial Pharmaceuticals, Inc.. Compared to the previous quarter, the number grew by 7.25% or 117.90K shares more. As for the holding position changes, 25% (3) of current hedge fund investors increased the number of shares held, 25% (3) of current holders sold a part of the shares held, and 16.67% (2) closed the holdings completely. 2 hedge funds are new holders of Adial Pharmaceuticals, Inc. stock in Q1 2023, it is 16.67% of total holders.
Hedge funds holding Adial Pharmaceuticals (Q3 2018 – Q1 2023)
| Q3 2018 | 5 |
|---|---|
| Q4 2018 | 8 |
| Q1 2019 | 12 |
| Q2 2019 | 9 |
| Q3 2019 | 10 |
| Q4 2019 | 8 |
| Q1 2020 | 10 |
| Q2 2020 | 10 |
| Q3 2020 | 14 |
| Q4 2020 | 13 |
| Q1 2021 | 18 |
| Q2 2021 | 18 |
| Q3 2021 | 19 |
| Q4 2021 | 22 |
| Q1 2022 | 22 |
| Q2 2022 | 25 |
| Q3 2022 | 20 |
| Q4 2022 | 20 |
| Q1 2023 | 12 |
Hedge funds changes in Adial Pharmaceuticals positions (Q3 2018 – Q1 2023)
| Q3 2018 | 5 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2018 | 6 | 1 | 0 | 3 | -2 |
| Q1 2019 | 4 | 6 | 0 | 0 | 2 |
| Q2 2019 | 1 | 0 | 3 | 4 | 1 |
| Q3 2019 | 3 | 2 | 1 | 2 | 2 |
| Q4 2019 | 0 | 1 | 0 | 2 | 5 |
| Q1 2020 | 3 | 0 | 0 | 0 | 7 |
| Q2 2020 | 2 | 0 | 1 | 2 | 5 |
| Q3 2020 | 5 | 1 | 1 | 1 | 6 |
| Q4 2020 | 2 | 2 | 2 | 3 | 4 |
| Q1 2021 | 6 | 5 | 3 | 1 | 3 |
| Q2 2021 | 4 | 5 | 4 | 4 | 1 |
| Q3 2021 | 5 | 7 | 2 | 4 | 1 |
| Q4 2021 | 4 | 3 | 4 | 1 | 10 |
| Q1 2022 | 4 | 6 | 1 | 4 | 7 |
| Q2 2022 | 7 | 5 | 3 | 4 | 6 |
| Q3 2022 | 5 | 5 | 3 | 9 | -2 |
| Q4 2022 | 4 | 5 | 3 | 4 | 4 |
| Q1 2023 | 2 | 3 | 3 | 2 | 2 |
Hedge funds changes in Adial Pharmaceuticals stock options (Q3 2018 – Q1 2023)
| Q3 2018 | 0 | 0 |
|---|---|---|
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 224,000 | 0 |
| Q4 2021 | 249,000 | 0 |
| Q1 2022 | 154,000 | 68,000 |
| Q2 2022 | 157,000 | 0 |
| Q3 2022 | 1,000 | 0 |
| Q4 2022 | 0 | 0 |
| Q1 2023 | 0 | 0 |